News

Experts in newest treatment option for cancer, neurological disorders unite to speed progress, expand access Consortium members will share resources, collaborate on clinical trials Statewide experts look to expand benefits... Read more

Video of Research at Risk: Stopping metastatic cancer Metastasis. It’s the word cancer patients dread most – and the scan with ominous black spots showing the disease has spread. For too many people, metastatic cancer is... Read more

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new... Read more

Dr. Juan R. Cubillos-Ruiz , the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden , the Stavros S. Niarchos Professor in Pediatric... Read more

Weill Cornell Medicine has received a projected $4 million grant from the National Cancer Institute, part of the National Institutes of Health, to conduct a clinical trial testing whether a new imaging approach could reduce... Read more

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers. The... Read more

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling,... Read more

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a... Read more

Linoleic acid, an omega-6 fatty acid found in seed oils such as soybean and safflower oil, and animal products including pork and eggs, specifically enhances the growth of the hard-to-treat “triple negative” breast cancer... Read more